Recent Episodes
-
AI for Rare Disease: From Discovery to Trials, Smarter and Faster
May 29, 2025 – 00:37:48 -
Improving Alignment In Drug Development
Apr 28, 2025 – 00:36:35 -
Breaking Barriers
Mar 31, 2025 – 00:27:44 -
P4A's 5 Top Trends for 2025
Jan 31, 2025 – 00:27:22 -
The JCA is live
Jan 13, 2025 – 00:25:24 -
Innovative Treatments for Cutaneous T-Cell Lymphoma with Leonard Mazur of Citius Pharmaceuticals
Nov 19, 2024 – 00:26:21 -
Amplifying Patient Voices: Wes Michael on Rare Disease Advocacy
Oct 10, 2024 – 00:23:54 -
Impact of Mergers, Acquisitions, and Patent Expirations on Job Cuts in Pharma and Biotech: Insights from Aurelija Luko and Darren Callanan
Jul 2, 2024 – 00:27:15 -
The Role of Patient Experience Data in Drug Development with Pina Haberl and Sam Morrison
May 3, 2024 – 00:34:37 -
World EPA Conference 2024 Special
Apr 10, 2024 – 00:28:54 -
Rare Disease Day Special 2024: The Role of Genetic Diagnosis in Rare Conditions with Nick Meade
Feb 29, 2024 – 00:24:31 -
Celebrating 5 Years of P4A: Reflections on Rare Diseases, Cell and Gene Therapies, and Legislation in Europe
Jan 2, 2024 – 00:53:45 -
Revolutionizing Patient Outcomes: The Power of Digital Health Solutions with RJ Kedziora
Dec 1, 2023 – 00:28:02 -
The Future of Patient Engagement and the Role of Technology in Healthcare with Iola Forster
Oct 6, 2023 – 00:23:38 -
Navigating the New EU HTA Regulation and Its Impact on ATMP Development
Jul 31, 2023 – 00:16:35 -
Alejandro Dorenbaum, CMO of Reneo Pharmaceuticals Discusses Clinical-Stage Therapies
Jun 1, 2023 – 00:16:14 -
Interview with Xortx Therapeutics CEO, Dr Allen Davidoff discussing their journey from early development to potential launch
Apr 29, 2023 – 00:19:22 -
World EPA Congress 2023 Special
Apr 17, 2023 – 00:24:09 -
Rare Disease Day Special 2023
Feb 28, 2023 – 00:40:03 -
Trends to look out for in 2023
Feb 3, 2023 – 00:44:17 -
World Orphan Drug Congress Europe 2022 Special
Dec 20, 2022 – 00:42:39 -
Winds of change for German Healthcare Market!
Oct 31, 2022 – 00:38:42 -
Part 2 -Patient Empowerment: Is it a no-brainer?
Oct 3, 2022 – 00:28:25 -
Part 1 Patient Empowerment; Why involving patients from early drug development through to launch is a no-brainer!
Sep 13, 2022 – 00:31:08 -
What makes P4A an award winning consultancy?
Jul 29, 2022 – 00:15:03 -
Special Episode with EUCOPE-Part 2 with Alexander Natz
Jun 30, 2022 – 00:28:57 -
Special series with Eucope: Part 1 featuring Victor Maertens
May 31, 2022 – 00:24:51 -
China market access: obstacle or opportunity for orphan drug, cell and gene therapy manufacturers?
Apr 29, 2022 – 00:10:27 -
Should the Middle East be a priority launch market for orphan drug manufacturers?
Mar 31, 2022 – 00:12:34 -
Rare Disease Day Special featuring Janet Bloor and Nick Meade - February 2022
Feb 28, 2022 – 00:28:47 -
P4A Insights: Trends to look out for in 2022
Feb 4, 2022 – 00:10:32 -
Special episode - Bluebird Bio: What went wrong? -December 2021:
Dec 13, 2021 – 00:17:15 -
Special episode featuring James Mackay - November 2021
Nov 30, 2021 – 00:23:59 -
Monthly Roundup - October 2021
Oct 29, 2021 – 00:10:59 -
Monthly RoundUp - September 2021
Sep 30, 2021 – 00:15:41 -
Monthly RoundUp: July 2021
Jul 30, 2021 – 00:15:01 -
Monthly RoundUp - June 2021
Jun 30, 2021 – 00:07:43 -
Monthly RoundUp - May 2021
May 31, 2021 – 00:09:32 -
Monthly RoundUp - April 2021
Apr 30, 2021 – 00:20:58 -
Monthly RoundUp - March 2021
Mar 31, 2021 – 00:13:22 -
Monthly RoundUp - February 2021
Feb 27, 2021 – 00:22:50 -
Rare Disease Day special episode: Reclaiming the rare disease patient’s voice
Jan 29, 2021 – 00:36:55 -
End of year 2020 review
Dec 21, 2020 – 00:18:03 -
Special episode: Gene Therapy access from a specialty pharmacy perspective
Jun 22, 2020 – 00:20:50 -
Weekly RoundUp: February 29, 2020
Feb 29, 2020 – 00:17:56 -
Weekly Roundup: December 30, 2019
Dec 30, 2019 – 00:09:56 -
Weekly Roundup: December 23, 2019
Dec 23, 2019 – 00:04:54 -
Weekly Roundup: November 12, 2019
Nov 12, 2019 – 00:14:27 -
Weekly Roundup: November 5, 2019
Nov 5, 2019 – 00:08:15 -
Weekly RoundUp: August 5, 2019
Aug 5, 2019 – 00:18:35
Recent Reviews
Similar Podcasts
Disclaimer: The podcast and artwork on this page are property of the podcast owner, and not endorsed by UP.audio.